...
首页> 外文期刊>Neuropathology and applied neurobiology >Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid?polyneuropathy due to transthyretin Ala97Ser
【24h】

Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid?polyneuropathy due to transthyretin Ala97Ser

机译:在小鼠模型中的感觉神经变性模拟了家庭淀粉样蛋白的早期表现?由于Transthyretin Ala97ser引起的多变病变

获取原文
获取原文并翻译 | 示例
           

摘要

Aims Sensory nerve degeneration and consequent abnormal sensations are the earliest and most prevalent manifestations of familial amyloid polyneuropathy (FAP) due to amyloidogenic transthyretin (TTR). FAP is a relentlessly progressive degenerative disease of the peripheral nervous system. However, there is a lack of mouse models to replicate the early neuropathic manifestations of FAP. Methods We established human TTR knock‐in mice by replacing one allele of the mouse Ttr locus with human wild‐type TTR (hTTR wt ) or human TTR with the A97S mutation (hTTR A97S ). Given the late onset of neuropathic manifestations in A97S‐FAP, we investigated nerve pathology, physiology, and behavioural tests in these mice at two age points: the adult group (8 – 56?weeks) and the ageing group (?104?weeks). Results In the adult group, nerve profiles, neurophysiology and behaviour were similar between hTTR wt and hTTR A97S mice. By contrast, ageing hTTR A97S mice showed small fibre neuropathy with decreased intraepidermal nerve fibre density and behavioural signs of mechanical allodynia. Furthermore, significant reductions in sural nerve myelinated nerve fibre density and sensory nerve action potential amplitudes in these mice indicated degeneration of large sensory fibres. The unaffected motor nerve physiology replicated the early symptoms of FAP patients, that is, sensory nerves were more vulnerable to mutant TTR than motor nerves. Conclusions These results demonstrate that the hTTR A97S mouse model develops sensory nerve pathology and corresponding physiology mimicking A97S‐FAP and provides a platform to develop new therapies for the early stage of A97S‐FAP.
机译:目的感觉神经变性和随之而来的异常感觉是由于淀粉样蛋白Transthyretin(TTR)引起的家族性淀粉样蛋白多变病变(FAP)的最早和最普遍的表现。 FAP是周围神经系统的无情渐进性疾病。然而,缺乏小鼠模型以复制FAP的早期神经疗法表现。方法通过使用人类野生型TTR(HTTR WT)或HANE TTR与A97S突变(HTTR A97S)替换一个等位基因,通过用人野生型TTR(HTTR WT)或人体TTR来建立人类TTR敲入小鼠。鉴于A97S-FAP中神经疗法表现的后期发作,我们在两龄点处调查了这些小鼠的神经病理,生理学和行为试验:成人组(8-56?周)和老化组(&?104?周)。结果在HTTR WT和HTTR A97S小鼠之间具有相似的成人组,神经谱,神经肌肉学和行为。相比之下,老化HTTR A97S小鼠表现出小的纤维神经病变,降低了机械异常性疾病的脑内神经纤维密度和行为迹象。此外,在这些小鼠中显着降低了这些小鼠中的血管神经肌肉神经纤维密度和感觉神经动作电位振幅,表明大型感觉纤维的变性。未受影响的运动神经生理学复制FAP患者的早期症状,即感觉神经比电机神经更容易受到突变的TTR。结论这些结果表明,HTTR A97S小鼠模型显影了MIMICING A97S-FAP的感觉神经病理学和相应的生理学,并为A97S-FAP早期开发了新疗法的平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号